Caldwell Sutter Capital, Inc. Rx Sight, Inc. Transaction History
Caldwell Sutter Capital, Inc.
- $210 Billion
- Q1 2025
A detailed history of Caldwell Sutter Capital, Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 200 shares of RXST stock, worth $2,884. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 220
9.09%
Holding current value
$2,884
Previous $7.56 Million
33.24%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RXST
# of Institutions
222Shares Held
33.5MCall Options Held
531KPut Options Held
50.1K-
Ra Capital Management, L.P. Boston, MA3.74MShares$54 Million2.08% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$34.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$34.4 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.16MShares$31.1 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.55MShares$22.4 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $399M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...